15833469|t|Common symptoms in advanced cancer.
15833469|a|The key points of this article are anorexia and cachexia are: A major cause of cancer deaths. Several drugs are available to treat anorexia and cachexia. Dyspnea in cancer usually is caused by several factors. Treatment consists of reversing underlying causes, empiric bronchodilators, cortico-steroids--and in the terminally ill patients-opioids, benzodiazepines,and chlorpromazine. Delirium is associated with advanced cancer. Empiric treatment with neuroleptics while evaluating for reversible causes is a reasonable approach to management. Nausea and vomiting are caused by extra-abdominal factors (drugs,electrolyte abnormalities, central nervous system metastases) or intra-abdominal factors (gastroparesis, ileus, gastric outlet obstruction, bowel obstruction). The pattern of nausea and vomiting differs depending upon whether the cause is extra- or intra-abdominal. Reversible causes should be sought and empiric metoclopramide or haloperidol should be initiated. Fatigue may be caused by anemia, depression, endocrine abnormalities,or electrolyte disturbances that should be treated before using empiric methylphenidate. Constipation should be treated with laxatives and stool softeners. Both should start with the first opioid dose.
15833469	28	34	cancer	Disease	MESH:D009369
15833469	71	79	anorexia	Disease	MESH:D000855
15833469	84	92	cachexia	Disease	MESH:D002100
15833469	115	121	cancer	Disease	MESH:D009369
15833469	167	175	anorexia	Disease	MESH:D000855
15833469	180	188	cachexia	Disease	MESH:D002100
15833469	190	197	Dyspnea	Disease	MESH:D004417
15833469	201	207	cancer	Disease	MESH:D009369
15833469	330	338	steroids	Chemical	MESH:D013256
15833469	366	374	patients	Species	9606
15833469	384	399	benzodiazepines	Chemical	MESH:D001569
15833469	404	418	chlorpromazine	Chemical	MESH:D002746
15833469	420	428	Delirium	Disease	MESH:D003693
15833469	457	463	cancer	Disease	MESH:D009369
15833469	580	590	Nausea and	Disease	MESH:D009325
15833469	591	599	vomiting	Disease	MESH:D014839
15833469	645	670	electrolyte abnormalities	Disease	MESH:D014883
15833469	672	705	central nervous system metastases	Disease	MESH:D009362
15833469	735	748	gastroparesis	Disease	MESH:D018589
15833469	750	755	ileus	Disease	MESH:D045823
15833469	757	783	gastric outlet obstruction	Disease	MESH:D017219
15833469	785	802	bowel obstruction	Disease	MESH:D012778
15833469	820	830	nausea and	Disease	MESH:D009325
15833469	831	839	vomiting	Disease	MESH:D014839
15833469	958	972	metoclopramide	Chemical	MESH:D008787
15833469	976	987	haloperidol	Chemical	MESH:D006220
15833469	1009	1016	Fatigue	Disease	MESH:D005221
15833469	1034	1040	anemia	Disease	MESH:D000740
15833469	1042	1052	depression	Disease	MESH:D003866
15833469	1054	1077	endocrine abnormalities	Disease	MESH:D004700
15833469	1081	1105	electrolyte disturbances	Disease	MESH:D014883
15833469	1150	1165	methylphenidate	Chemical	MESH:D008774
15833469	1167	1179	Constipation	Disease	MESH:D003248
15833469	Negative_Correlation	MESH:D008774	MESH:D005221
15833469	Negative_Correlation	MESH:D002746	MESH:D009369
15833469	Negative_Correlation	MESH:D008774	MESH:D004700
15833469	Negative_Correlation	MESH:D008774	MESH:D014883
15833469	Negative_Correlation	MESH:D006220	MESH:D014839
15833469	Negative_Correlation	MESH:D001569	MESH:D004417
15833469	Negative_Correlation	MESH:D008787	MESH:D009325
15833469	Negative_Correlation	MESH:D013256	MESH:D009369
15833469	Negative_Correlation	MESH:D002746	MESH:D000855
15833469	Negative_Correlation	MESH:D008774	MESH:D000740
15833469	Negative_Correlation	MESH:D008787	MESH:D014839
15833469	Negative_Correlation	MESH:D006220	MESH:D009325
15833469	Negative_Correlation	MESH:D013256	MESH:D004417
15833469	Negative_Correlation	MESH:D002746	MESH:D004417
15833469	Negative_Correlation	MESH:D008774	MESH:D003866

